Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205–215]. (June 2017)

Record Type:: Journal Article
Title:: Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205–215]. (June 2017)
Main Title:: Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205–215]
Authors:: Gómez-Cañas, M.
Morales, P.
García-Toscano, L.
Navarrete, C.
Muñoz, E.
Jagerovic, N.
Fernández-Ruiz, J.
García-Arencibia, M.
Pazos, M.R.
Abstract:
Is Part Of:: Pharmacological research. Volume 120(2017:Jun.)
Journal:: Pharmacological research
Issue:: Volume 120(2017:Jun.)
Issue Display:: Volume 120 (2017)
Year:: 2017
Volume:: 120
Issue Sort Value:: 2017-0120-0000-0000
Page Start:: 302
Page End:
Publication Date:: 2017-06
Subjects:: Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105
Journal URLs:: http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.phrs.2017.04.002 ↗
Languages:: English
ISSNs:: 1043-6618
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 2315.xml